compound semaglutide or tirzepatide vs Tirzepatide vs. Semaglutide: What You
Description
Paid in full
This is about all and not just about the approval of some medication
Retatrutide clinical trials and preliminary results Eli Lilly, the manufacturer of Retatrutide, completed their Phase II trials and released results in June 2023
The STEP-1 trial tested the effect of high-dose semaglutide to produce weight loss in people with obesity who do not have diabetes
This retatrutide data shows that Lilly may be able to develop a drug that is even better than the most effective treatments currently available
For additional background on telehealth GLP-1 programs and how they work, see our comprehensive consumer guide to Elevate Health's platform structure
